{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:02:07Z","timestamp":1777647727085,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ajog.2013.01.010","type":"journal-article","created":{"date-parts":[[2013,1,10]],"date-time":"2013-01-10T17:17:25Z","timestamp":1357838245000},"page":"303.e1-303.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay"],"prefix":"10.1016","volume":"208","author":[{"given":"Emmanuel","family":"Spaggiari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Ruas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Dreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sylvie","family":"Valat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Czerkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Guimiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Lise","family":"Delezoide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.01.010_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0029-7844(97)00151-8","article-title":"Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population","volume":"89","author":"Hsieh","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib2","first-page":"214","article-title":"Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal\/fetal outcome: ten years experience","volume":"78","author":"Anfuso","year":"2007","journal-title":"Acta Biomed"},{"key":"10.1016\/j.ajog.2013.01.010_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(72)91634-0","article-title":"Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida","volume":"2","author":"Brock","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2013.01.010_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(74)92838-4","article-title":"Prenatal diagnosis of spina bifida and anencephaly by maternal serum-alpha-fetoprotein measurement","volume":"1","author":"Wald","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2013.01.010_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(84)92389-4","article-title":"Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome","volume":"1","author":"Cuckle","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2013.01.010_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/0002-9378(93)90613-N","article-title":"A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol","volume":"169","author":"Burton","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib8","first-page":"465","article-title":"Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses","volume":"65","author":"Hamilton","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib9","first-page":"709","article-title":"Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein","volume":"72","author":"Burton","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM199107043250102","article-title":"Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death","volume":"325","author":"Waller","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2013.01.010_bib11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0029-7844(96)00310-9","article-title":"The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications","volume":"88","author":"Waller","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1067\/S0002-9378(03)00769-5","article-title":"Unexplained elevated maternal serum alpha-fetoprotein and\/or human chorionic gonadotropin and the risk of adverse outcomes","volume":"189","author":"Chandra","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib13","first-page":"277","article-title":"Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome","volume":"97","author":"Krause","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.04.017","article-title":"Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk?","volume":"145","author":"Yuan","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2013.01.010_bib15","first-page":"906","article-title":"Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele","volume":"71","author":"Palomaki","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib16","first-page":"852","article-title":"Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects","volume":"84","author":"Saller","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0002-9378(11)91711-6","article-title":"Congenital nephrosis: detection of index cases through maternal serum alpha-fetoprotein screening","volume":"167","author":"Hogge","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1097-0223(199603)16:3<207::AID-PD834>3.0.CO;2-K","article-title":"Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease","volume":"16","author":"Heinonen","year":"1996","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.010_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ajmg.1320470320","article-title":"Prenatal detection of epidermolysis bullosa letalis with pyloric atresia in a fetus by abnormal ultrasound and elevated alpha-fetoprotein","volume":"47","author":"Dolan","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2013.01.010_bib20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/pd.438","article-title":"Second trimester trisomy 21 maternal serum marker screening: results of a countrywide study of 854,902 patients","volume":"22","author":"Muller","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.010_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jcp.38.4.473","article-title":"Rapid falls in maternal serum alpha-fetoprotein concentrations","volume":"38","author":"Bredow","year":"1985","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ajog.2013.01.010_bib22","first-page":"1042","article-title":"Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction","volume":"76","author":"Grau","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1471-0528.1996.tb09873.x","article-title":"The relation between serum markers in the second trimester and placental pathology: a study on extremely small for gestational age fetuses","volume":"103","author":"Morssink","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0002-9378(83)91091-8","article-title":"Elevated maternal serum alpha-fetoprotein levels associated with breakdown in fetal-maternal-placental barrier","volume":"146","author":"Berkeley","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.01.010_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/pd.1970150513","article-title":"Amniotic alpha-fetoprotein in the prenatal diagnosis of congenital nephrotic syndrome of the Finnish type","volume":"15","author":"Morris","year":"1995","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.010_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/pd.1349","article-title":"Prenatal diagnosis of inherited epidermolysis bullosa in a patient with no family history: a case report and literature review","volume":"26","author":"Azarian","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2013.01.010_bib27","first-page":"71","article-title":"Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies","volume":"79","author":"Bernstein","year":"1992","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781300046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781300046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:51:20Z","timestamp":1757587880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293781300046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S000293781300046X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.01.010","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}